Our findings in this work appeared to be inconsistent with the results reported by previous studies demonstrating that patients with NSCLC had an increase in plasma anti-CD25b IgG levels24,25 and that plasma anti-FOXP3 IgG levels were found to be increased in the early stage of esophageal cancer27. Here, FOXP3 is linked to non-small cell lung carcinoma.